10 Stock Market News for "AZRE"

B. Riley FBR to Host Consumer & Media Conference in New York

LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) — B. Riley FBR, Inc., a full-service investment bank and subsidiary of B. Riley Financial, Inc. (NASDAQ:RILY), today announced its 5th Annual Consumer & Media Conference will be held at the Sofitel New York on Thursday, October 3, 2019.The invitation-only event provides companies and management teams across the consumer, leisure, and media sect... »

Precision Stainless Steel Market to Grow 1.5x by 2029 – Future Market Insights

VALLEY COTTAGE, N.Y. , July 09, 2019 (GLOBE NEWSWIRE) — Future Market Insights provides critical insights on the precision stainless steel market, in its published report, which includes the global industry analysis 2014-2018 and opportunity assessment 2019-2029. In terms of market value, the global precision stainless steel market is projected to expand at a CAGR of over 4% during the ... »

Earnings Scheduled For June 10, 2019

Companies Reporting Before The Bell Thor Industries, Inc. (NYSE: THO) is expected to report quarterly earnings at $1.64 per share on revenue of $2.63 billion. Shiloh Industries, Inc. (NASDAQ: SHLO) is projected to report quarterly loss at $0.03 per share on revenue of $286.80 million. Ferrellgas Partners, L.P. (NYSE: FGP) is expected to report quarterly earnings at $0.20 per share on revenue of $5... »

Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors

FivePrime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stagebiotechnology company focused on discovering and developing innovativeimmuno-oncology protein therapeutics, today announced the departure ofDr. Sheila Gujrathi from the company’s board of directors. Dr. Gujrathihas served as a board member of Five Prime since December 2015 and isstepping down from the board to focus on her role as P... »

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

FivePrime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stagebiotechnology company focused on discovering and developing innovativeimmuno-oncology protein therapeutics today announced that AronKnickerbocker, Chief Executive Officer, is scheduled to present at thefollowing two investor conferences: The Raymond James Life Sciences and MedTech Conference, on Wednesday,June 19th at 1:15pm ET / 10:... »

Five Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today presented monotherapy data from the dose escalation portion of the Phase 1a/1b clinical trial of FPA150 in patients with advanced solid tumors. These data were presen... »

Smithfield Foods Awarded “Best for Vets” 2019 Employer Ranking

SMITHFIELD, Va., May 30, 2019 (GLOBE NEWSWIRE) — Smithfield Foods, Inc., a global food company and the world’s largest pork processor and hog producer, announced today its recognition by Military Times in the publication’s Best for Vets Employers 2019 rankings. The rankings, awarded during National Military Month, recognize companies for their efforts to recruit and support service members, ... »

Five Prime Therapeutics Appoints Carol Schafer to its Board of Directors

FivePrime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stagebiotechnology company focused on discovering and developing innovativeimmuno-oncology protein therapeutics, today announced the appointment ofCarol Schafer to its Board of Directors. Ms. Schafer is an industryleader with more than 25 years of investment banking and equity capitalmarkets experience in the biotechnology sector. “We we... »

Five Prime Therapeutics Announces FPA150 Poster Presentation at the 2019 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced an upcoming poster presentation at the 2019 ASCO Annual Meeting being held in Chicago, May 31 – June 4, 2019. Data will be presented from the Phase 1a/1b st... »

Five Prime Therapeutics Reports First Quarter 2019 Results

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced its results for the first quarter and provided an update on the company’s recent activities. The company also provided an update on the Phase 3 FIGHT t... »